WHO hopes for hundreds of millions of vaccine doses this year, 2 billion next year
EU In Talks With Johnson & Johnson For Covid-19 Vaccine Deal
2 “Strong Buy” Small-Cap Stocks That Could See Outsized Gains
Cellular nanosponges could soak up SARS-CoV-2
Moderna (MRNA) Stock Is a Winner, But How Much Higher Can It Go?
Fred Hutch and University of Washington experts: Treat COVID-19 earlier to save lives
UK stops recruitment to hydroxychloroquine COVID-19 trials
TERAVOLT registry tracks outcomes among thoracic cancer patients sickened by COVID-19
Exercise offers ‘profound’ benefits for Friedreich’s ataxia, research suggests
UK’s Imperial College begins trial of coronavirus vaccine
Talking vaccines: Industry’s role in protecting the Gavi generation
The FDA backs off a hasty — and damaging — emergency OK for a potentially dangerous Covid-19 drug
Mutation in new coronavirus increases chance of infection: study
’Omics in Translation
FDA Withdraws Emergency Authorization For Hydroxychloroquine After HHS Official Makes Request
Will Clinical Trials Make a House Call?
Fast COVID-19 vaccine timelines are unrealistic and put the integrity of scientists at risk
Coronavirus pharma news roundup – 12/06/20
3 “Strong Buy” Penny Stocks With Massive Upside Ahead
Regeneron Starts Human Clinical Trials Of Covid-19 Antibody Cocktail
Finding health care companies we believe can thrive in a post-COVID-19 environment
Moderna to start final testing stage of coronavirus vaccine in July
Lilly CSO: COVID-19 Antibody Treatment Could Be Ready by Fall 2020
Lilly COVID-19 treatment could be authorized for use as soon as September
Responding to challenges of older adults with COVID-19
Strengthening Africa’s clinical trial capacity through an online platform
How should you think about the prospects for a vaccine?
Royalty Pharma plans largest IPO of the year so far
Digital health predicted as the new normal in COVID aftermath
A drug for the treatment of COVID-19 complications is registered in Russia